Fig. 1
From: Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort
Kaplan–Meier curves showing drug survival of immunosuppressive/antiproliferative agents in 181 patients with systemic sclerosis. Mean disease duration: 11.8 ± 8.4 years, mean + SD. AZA = azathioprine, CYC = cyclophosphamide, MMF = mycophenolate mofetil, MTX = methotrexate